Phase 3 Inflammatory Bowel Disease Clinical Trials
11 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–11 of 11 trials
Recruiting
Phase 3
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Inflammatory Bowel DiseasesCrohn's DiseaseUlcerative Colitis+1 more
Eli Lilly and Company150 enrolled66 locationsNCT04844606
Recruiting
Phase 2Phase 3
Activation of Autophagy and Suppression of Apoptosis by Dapagliflozin Attenuates Inflammatory Bowel Disease
Inflammatory Bowel Diseases
Mostafa Bahaa50 enrolled1 locationNCT05986136
Recruiting
Phase 3
Transfer of FRozen Encapsulated Multidonor Stool Filtrate for Active Ulcerative COlitis
Inflammatory Bowel DiseasesUlcerative Colitis
Andreas Stallmach129 enrolled20 locationsNCT03843385
Recruiting
Phase 3
Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease
Inflammatory Bowel DiseasesCrohn's Disease
Weill Medical College of Cornell University120 enrolled1 locationNCT06274554
Recruiting
Phase 2Phase 3
Evaluate the Efficacy and Safety of Probiotic 6600 as an Adjuvant Therapy for Colitis
ColitisIBD (Inflammatory Bowel Disease)Probiotic Intervention
Changhai Hospital120 enrolled1 locationNCT07047339
Recruiting
Phase 2Phase 3
Fenofibrate in Ulcerative Colitis
Inflammatory Bowel Diseases
Tanta University60 enrolled1 locationNCT05753267
Recruiting
Phase 2Phase 3
Unravelling Intestinal Fibrosis in Ulcerative Colitis
Fibroblast Activation Protein InhibitorUlcerative Colitis (UC)Inflammatory Bowel Disease (IBD)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)10 enrolled1 locationNCT06604273
Recruiting
Phase 2Phase 3
Standardized Fecal Microbiota Transplantation for Ulcerative Colitis
Ulcerative ColitisMicrobiotaInflammatory Bowel Disease+2 more
The Second Hospital of Nanjing Medical University500 enrolled1 locationNCT01790061
Recruiting
Phase 3Phase 4
De novo combination allopurinol-thiopurine vs standard thiopurine in inflammatory bowel disease (IBD) patients escalating to immunomodulators: a randomized controlled trial
Inflammatory Bowel Disease
Eastern Health140 enrolled7 locationsACTRN12613001347752
Completed
Phase 3Phase 4
Use of Ajunctive Allopurinol in Azathioprine/6-Mercaptopurine Non-responders to Optimize 6-Thioguanine Nucleotide Production and Improve Clinical Outcomes in Patients with Inflammatory Bowel Disease (IBD).
Inflammatory Bowel Disease (IBD)
The Alfred Hospital78 enrolled1 locationACTRN12611000363987
Completed
Phase 3
Human Papilloma Virus (HPV) Vaccination in Special Risk Groups
Special Risk Groups
1. Paediatric Rheumatalogical Disease
2. Inflammatory Bowel Disease
3. Acute Lymphoblastic Leukaemia
4. Solid Organ Transplant Recipients (kidney and liver)
5. Chronic Renal Disease
6. Bone Marrow Transsplant
The response to the HPV vaccine will be studied within these 6 special risk groups.
National Health and Medical Research Council & Clinical Centre of Research Excellence(NHMRC CCRE) in Childhood and Adolescent Immunisation100 enrolled1 locationACTRN12609000571279